High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men
Elucidating virus-host interactions responsible for HIV-1 transmission is important for advancing HIV-1 prevention strategies. To this end, single genome amplification (SGA) and sequencing of HIV-1 within the context of a model of random virus evolution has made possible for the first time an unambiguous identification of transmitted/founder viruses and a precise estimation of their numbers. Here, we applied this approach to HIV-1 env analyses in a cohort of acutely infected men who have sex with men (MSM) and found that a high proportion (10 of 28; 36%) had been productively infected by more than one virus. In subjects with multivariant transmission, the minimum number of transmitted viruses ranged from 2 to 10 with viral recombination leading to rapid and extensive genetic shuffling among virus lineages. A combined analysis of these results, together with recently published findings based on identical SGA methods in largely heterosexual (HSX) cohorts, revealed a significantly higher frequency of multivariant transmission in MSM than in HSX [19 of 50 subjects (38%) versus 34 of 175 subjects (19%); Fisher's exact p = 0.008]. To further evaluate the SGA strategy for identifying transmitted/founder viruses, we analyzed 239 overlapping 5′ and 3′ half genome or env-only sequences from plasma viral RNA (vRNA) and blood mononuclear cell DNA in an MSM subject who had a particularly well-documented virus exposure history 3–6 days before symptom onset and 14–17 days before peak plasma viremia (47,600,000 vRNA molecules/ml). All 239 sequences coalesced to a single transmitted/founder virus genome in a time frame consistent with the clinical history, and a molecular clone of this genome encoded replication competent virus in accord with model predictions. Higher multiplicity of HIV-1 infection in MSM compared with HSX is consistent with the demonstrably higher epidemiological risk of virus acquisition in MSM and could indicate a greater challenge for HIV-1 vaccines than previously recognized.
Vyšlo v časopise:
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000890
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000890
Souhrn
Elucidating virus-host interactions responsible for HIV-1 transmission is important for advancing HIV-1 prevention strategies. To this end, single genome amplification (SGA) and sequencing of HIV-1 within the context of a model of random virus evolution has made possible for the first time an unambiguous identification of transmitted/founder viruses and a precise estimation of their numbers. Here, we applied this approach to HIV-1 env analyses in a cohort of acutely infected men who have sex with men (MSM) and found that a high proportion (10 of 28; 36%) had been productively infected by more than one virus. In subjects with multivariant transmission, the minimum number of transmitted viruses ranged from 2 to 10 with viral recombination leading to rapid and extensive genetic shuffling among virus lineages. A combined analysis of these results, together with recently published findings based on identical SGA methods in largely heterosexual (HSX) cohorts, revealed a significantly higher frequency of multivariant transmission in MSM than in HSX [19 of 50 subjects (38%) versus 34 of 175 subjects (19%); Fisher's exact p = 0.008]. To further evaluate the SGA strategy for identifying transmitted/founder viruses, we analyzed 239 overlapping 5′ and 3′ half genome or env-only sequences from plasma viral RNA (vRNA) and blood mononuclear cell DNA in an MSM subject who had a particularly well-documented virus exposure history 3–6 days before symptom onset and 14–17 days before peak plasma viremia (47,600,000 vRNA molecules/ml). All 239 sequences coalesced to a single transmitted/founder virus genome in a time frame consistent with the clinical history, and a molecular clone of this genome encoded replication competent virus in accord with model predictions. Higher multiplicity of HIV-1 infection in MSM compared with HSX is consistent with the demonstrably higher epidemiological risk of virus acquisition in MSM and could indicate a greater challenge for HIV-1 vaccines than previously recognized.
Zdroje
1. HaaseAT
2005 Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 5 783 792
2. HladikF
McElrathMJ
2008 Setting the stage: host invasion by HIV. Nat Rev Immunol 8 447 457
3. PopeM
HaaseAT
2003 Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 9 847 852
4. ShattockRJ
MooreJP
2003 Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1 25 34
5. Rerks-NgarmS
PitisuttithumP
NitayaphanS
KaewkungwalJ
ChiuJ
2009 Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361 2209 2220
6. DolinR
2009 HIV vaccine trial results–an opening for further research. N Engl J Med 361 2279 2280
7. LetvinNL
2009 Moving forward in HIV vaccine development. Science 326 1196 1198
8. AbrahamsMR
AndersonJA
GiorgiEE
SeoigheC
MlisanaK
2009 Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol 83 3556 3567
9. HaalandRE
HawkinsPA
Salazar-GonzalezJ
JohnsonA
TichacekA
2009 Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 5 e1000274
10. KeeleBF
GiorgiEE
Salazar-GonzalezJF
DeckerJM
PhamKT
2008 Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105 7552 7557
11. Salazar-GonzalezJF
BailesE
PhamKT
SalazarMG
GuffeyMB
2008 Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 82 3952 3970
12. Salazar-GonzalezJF
SalazarMG
KeeleBF
LearnGH
GiorgiEE
2009 Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206 1273 1289
13. KeeleBF
LiH
LearnGH
HraberP
GiorgiEE
2009 Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med 206 1117 1134
14. DerdeynCA
DeckerJM
Bibollet-RucheF
MokiliJL
MuldoonM
2004 Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303 2019 2022
15. GottliebGS
HeathL
NickleDC
WongKG
LeachSE
2008 HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis 197 1011 1015
16. GroblerJ
GrayCM
RademeyerC
SeoigheC
RamjeeG
2004 Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis 190 1355 1359
17. LearnGH
MuthuiD
BrodieSJ
ZhuT
DiemK
2002 Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol 76 11953 11959
18. LongEM
MartinHLJr
KreissJK
RainwaterSM
LavreysL
2000 Gender differences in HIV-1 diversity at time of infection. Nat Med 6 71 75
19. PossM
MartinHL
KreissJK
GranvilleL
ChohanB
1995 Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 69 8118 8122
20. RitolaK
PilcherCD
FiscusSA
HoffmanNG
NelsonJA
2004 Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol 78 11208 11218
21. SagarM
KirkegaardE
LongEM
CelumC
BuchbinderS
2004 Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol 78 7279 7283
22. WolfsTF
ZwartG
BakkerM
GoudsmitJ
1992 HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189 103 110
23. WolinskySM
WikeCM
KorberBT
HuttoC
ParksWP
1992 Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255 1134 1137
24. ZhuT
MoH
WangN
NamDS
CaoY
1993 Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261 1179 1181
25. MargolisL
ShattockR
2006 Selective transmission of CCR5-utilizing HIV-1: the ‘gatekeeper’ problem resolved? Nat Rev Microbiol 4 312 317
26. MooreJP
KitchenSG
PugachP
ZackJA
2004 The CCR5 and CXCR4 coreceptors–central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 20 111 126
27. RichmanDD
BozzetteSA
1994 The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 169 968 974
28. LiQ
DuanL
EstesJD
MaZM
RourkeT
2005 Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 1148 1152
29. LiQ
EstesJD
SchlievertPM
DuanL
BrosnahanAJ
2009 Glycerol monolaurate prevents mucosal SIV transmission. Nature 458 1034 1038
30. LiQ
SkinnerPJ
HaSJ
DuanL
MattilaTL
2009 Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323 1726 1729
31. MillerCJ
LiQ
AbelK
KimEY
MaZM
2005 Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79 9217 9227
32. HladikF
SakchalathornP
BallweberL
LentzG
FialkowM
2007 Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26 257 270
33. FiebigEW
WrightDJ
RawalBD
GarrettPE
SchumacherRT
2003 Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17 1871 1879
34. LeeHY
GiorgiEE
KeeleBF
GaschenB
AthreyaGS
2009 Modeling sequence evolution in acute HIV-1 infection. J Theor Biol 261 341 360
35. KearneyM
MaldarelliF
ShaoW
MargolickJB
DaarES
2009 Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol 83 2715 2727
36. MornerA
BjorndalA
AlbertJ
KewalramaniVN
LittmanDR
1999 Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 73 2343 2349
37. MaydtJ
LengauerT
2006 Recco: recombination analysis using cost optimization. Bioinformatics 22 1064 1071
38. HudsonRR
KaplanNL
1985 Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 111 147 164
39. JungA
MaierR
VartanianJP
BocharovG
JungV
2002 Recombination: Multiply infected spleen cells in HIV patients. Nature 418 144
40. LevyDN
AldrovandiGM
KutschO
ShawGM
2004 Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A 101 4204 4209
41. ShrinerD
RodrigoAG
NickleDC
MullinsJI
2004 Pervasive genomic recombination of HIV-1 in vivo. Genetics 167 1573 1583
42. Simon-LoriereE
GalettoR
HamoudiM
ArcherJ
LefeuvreP
2009 Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog 5 e1000418
43. BimberBN
BurwitzBJ
O'ConnorS
DetmerA
GostickE
2009 Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J Virol 83 8247 8253
44. GoonetillekeN
LiuMK
Salazar-GonzalezJF
FerrariG
GiorgiE
2009 The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206 1253 1272
45. PilcherCD
FiscusSA
NguyenTQ
FoustE
WolfL
2005 Detection of acute infections during HIV testing in North Carolina. N Engl J Med 352 1873 1883
46. MehandruS
PolesMA
Tenner-RaczK
ManuelliV
Jean-PierreP
2007 Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol 81 599 612
47. VolkowP
BrouwerKC
LozaO
RamosR
LozadaR
2009 Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities. Int J Drug Policy 20 409 412
48. BarKJ
LiH
ChamberlandA
TremblayC
RoutyJP
2010 Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol xx yy zz
49. BoilyMC
Abu-RaddadL
DesaiK
MasseB
SelfS
2008 Measuring the public-health impact of candidate HIV vaccines as part of the licensing process. Lancet Infect Dis 8 200 207
50. BoilyMC
BaggaleyRF
WangL
MasseB
WhiteRG
2009 Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9 118 129
51. PhillipsAN
1996 Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271 497 499
52. LittleSJ
McLeanAR
SpinaCA
RichmanDD
HavlirDV
1999 Viral dynamics of acute HIV-1 infection. J Exp Med 190 841 850
53. StaffordMA
CoreyL
CaoY
DaarES
HoDD
2000 Modeling plasma virus concentration during primary HIV infection. J Theor Biol 203 285 301
54. MarkowitzM
LouieM
HurleyA
SunE
Di MascioM
2003 A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 77 5037 5038
55. BuckheitRW
WatsonKM
MorrowKM
HamAS
2010 Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res 85 142 158
56. VeazeyRS
ShattockRJ
PopeM
KirijanJC
JonesJ
2003 Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 9 343 346
57. ZhuJ
HladikF
WoodwardA
KlockA
PengT
2009 Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 15 886 892
58. Kosakovsky PondSL
PosadaD
GravenorMB
WoelkCH
FrostSD
2006 GARD: a genetic algorithm for recombination detection. Bioinformatics 22 3096 3098
59. RozasJ
Sanchez-DelBarrioJC
MesseguerX
RozasR
2003 DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19 2496 2497
60. WoodN
BhattacharyaT
KeeleBF
GiorgiE
LiuM
2009 HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog 5 e1000414
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 5
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Quorum Sensing Inhibition Selects for Virulence and Cooperation in
- The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
- Susceptibility to Anthrax Lethal Toxin-Induced Rat Death Is Controlled by a Single Chromosome 10 Locus That Includes
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species